Why Bellamy's and Bubs shares have rocketed higher this week

The Bellamy's Australia Ltd (ASX:BAL) share price and the Bubs Australia Ltd (ASX:BUB) share price have been on fire this week. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Two of the best performers on the All Ordinaries index this week have been the Bellamy's Australia Ltd (ASX: BAL) share price and the Bubs Australia Ltd (ASX: BUB) share price.

Both infant formula companies have smashed the market this week with gains of 20% and 28%, respectively, at the time of writing.

Why have these shares raced higher?

Whilst the Bellamy's share price is up strongly this week, the rampant buying of its shares has been going on for a little longer.

In fact, over the last 10 weeks the Bellamy's share price has rallied an incredible 55%. Investors appear to have taken advantage of a sharp share price decline last year to make a long-term and patient investment in the company.

Bellamy's shares fell after delays to attaining its SAMR accreditation meant that FY 2019 was going to be a tough year with sizeable declines in sales and profits.

But investors appear pleased that management remains confident that it will receive the accreditation and is ready to launch its Chinese marketing plans as soon as it is granted.

The Bubs share price has been on fire this week after announcing a potential joint venture with Beingmate Baby & Child Food Co. in Shanghai. If the joint venture goes ahead it will distribute and promote Bubs infant formula and organic baby food products in the massive China market.

Beingmate is a very experienced infant formula seller and has a wide distribution network that will undoubtedly be very helpful for Bubs.

However, investors appear to have overlooked the fact that Beingmate doesn't have the best track record.

Late last year there were reports that dairy giant Fonterra was unwinding its Australian dairy joint venture with Beingmate and considering the sale of its 18.8% stake in the company. At that point Beingmate was being threatened with delisting from the Shenzhen Stock Exchange and seeking financial support from the Chinese government.

So only time will tell whether this joint venture succeeds.

Which infant formula company should you buy?

Whilst Bellamy's shares are no longer the bargain buy they were before Christmas, I still see a lot of value in them if you're willing to make a buy and hold investment.

In addition to Bellamy's, I think rival A2 Milk Company Ltd (ASX: A2M) would be a great long term option as well.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »